Stabilised fibrate microparticles

Details for Australian Patent Application No. 2007201953 (hide)

Owner SkyePharma Canada, Inc.

Inventors Pace, Gary; Snow, Robert A.; Guivarc'h, Pol-Henri

Agent Peter Maxwell & Associates

Pub. Number AU-B-2007201953

Parent 2001255515

Filing date 1 May 2007

Wipo publication date 24 May 2007

Acceptance publication date 13 August 2009

International Classifications

A61K 31/216 (2006.01)

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/22 (2006.01)

A61K 31/365 (2006.01) - Lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/405 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 May 2007 Complete Application Filed

24 May 2007 Application Open to Public Inspection

  Published as AU-B-2007201953

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

26 March 2009 Section 223 Application Received

  SkyePharma Canada, Inc. An application to extend the time from 20 Apr 2008 to 20 Dec 2008 in which to pay a continuation fee has been filed . Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000 2008

14 May 2009 Section 223 Application Allowed

  SkyePharma Canada, Inc. The time in which to pay a continuation fee has been extended to 20 Dec 2008. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000

13 August 2009 Application Accepted

  Published as AU-B-2007201953

10 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201954-Regulatable, Catalytically Active Nucleic Acids

2007201952-Incontinence management system and diaper